MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Managed Care
November 2007
Martin Sipkoff
PBMs Agree to Disclose What They Pay for Drugs Pharmacy benefit managers will charge employers a straight administrative fee, rather than make much of their income through deals with the drug industry. mark for My Articles similar articles
Managed Care
September 2006
Martin Sipkoff
PBMs Raise the Curtain Efforts are under way to find out exactly how pharmacy benefit managers work their magic. mark for My Articles similar articles
The Motley Fool
November 3, 2010
Brian Orelli
A Generic Prescription for Double-Digit Growth MedcoHealth Solutions has it. mark for My Articles similar articles
Managed Care
March 2008
Martin Sipkoff
PBMs' Rebate Income Threatened By Lawsuits and Move to Generics A recent court settlement may affect the way the PBM industry makes profits, but could it also lead to higher drug costs? mark for My Articles similar articles
Managed Care
July 2004
Maureen Glabman
Wish List: 10 Things You Want From Your PBM One auditor estimates that 3 percent to 10 percent of pharmacy benefit manager (PBM) claims are processed incorrectly -- always in favor of the PBM. mark for My Articles similar articles
The Motley Fool
February 28, 2005
Brian Gorman
Medco Covers Its Bases Medco's purchase of Accredo is a nod to future growth in biotech drug spending. mark for My Articles similar articles
Managed Care
March 2005
MargaretAnn Cross
Transparency Catches Eye In Coalition's Deal With Medco A consortium of employers is paying the pharmacy benefit manager a new administration fee but taking all rebates and discounts. mark for My Articles similar articles
The Motley Fool
April 19, 2011
Bryan White
Rising Star Buy: Medco Health Medco has a much brighter future than its current stock price implies. mark for My Articles similar articles
The Motley Fool
July 29, 2004
Brian Gorman
Express Scripts' Bad Day Express Scripts joins other pharmacy benefit managers (PBM) embroiled in legal controversy. But the company, and its competitors, will eventually emerge from the fray and their stocks may then be worth another look. mark for My Articles similar articles
CFO
March 1, 2012
David McCann
Companies May Win This Drug War The conflict between Express Scripts and Walgreen just might lead to lower drug-benefit costs for companies. mark for My Articles similar articles
BusinessWeek
May 9, 2005
Weintraub & Barrett
BW 50: Can Caremark's Health Hold Up? Caremark Rx Inc. faces a growing set of legal and market challenges, but Its drug-benefit business is soaring, and its CEO remains upbeat about the future. mark for My Articles similar articles
The Motley Fool
June 13, 2005
Brian Gorman
Walgreen Strikes Back The traditional drugstore operator is expanding its mail-order business. This should be a welcome sign to investors. mark for My Articles similar articles
Managed Care
December 2001
Steven S. Martin
PBM Industry Today: Who's Managing Drug Costs? Health plans need to take a closer look. HMOs and employers alike will feel increasing pressure to give in to the desires of consumers... mark for My Articles similar articles
Managed Care
June 2005
PBMs Get Thumbs up From Satisfied Customers Pharmacy benefit managers that educate physicians on the safety and efficacy of generic drugs or provide them with generic drug samples to increase the use of generics get higher satisfaction ratings than those that don't. mark for My Articles similar articles
The Motley Fool
July 27, 2004
Brian Gorman
Medco's Pumped About Generics Generic drugs are actually helping improve Medco's margins, making it a winner with investors and health-care plans. mark for My Articles similar articles
Managed Care
September 2002
John Carroll
When Success Sours: PBMs Under Scrutiny Pharmacy benefit managers are under fire from many corners. What will the push for transparency mean for the industry? mark for My Articles similar articles
The Motley Fool
June 12, 2006
Brian Gorman
Biogeneric Payoff? A new report indicates that spending on specialty drugs increased 17.5% in 2005. This growth bodes well for makers of biotech drugs, which make up a large portion of the specialty drug category. Investors, take note. mark for My Articles similar articles
Managed Care
January 2001
Express Scripts' Formulary Rulings To Go Online The public will have a chance to see what until now has been, mostly, understood only by managed care insiders: how a prescription drug winds up on a formulary... mark for My Articles similar articles
The Motley Fool
February 14, 2005
Brian Gorman
GM Pulls Out of Walgreen The pharmacy's mail-order policy spurs the automaker's cost-containment decision. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2014
Jill Wechsler
Drug Coverage, Costs Under Scrutiny Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies mark for My Articles similar articles
Managed Care
September 2005
Headlines On Deadline ... WellPoint and Cigna are turning heads in the financial world... California health insurers have marked Jan. 1, 2007 on their calendars... etc. mark for My Articles similar articles
The Motley Fool
October 22, 2010
Roger Friedman
3 Health-Care Stocks for Your Watchlist There's money to be made in health care. But finding the right plays, especially among health care providers, can prove confounding. mark for My Articles similar articles
The Motley Fool
November 2, 2006
Ryan Fuhrmann
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 19, 2006
Matthew Crews
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. mark for My Articles similar articles
Managed Care
August 2002
Madeleine A. Estabrook
Regulators Take More Interest In Role of PBMs in Health Care In a highly regulated industry such as health care, it is just a matter of time before every component of the industry comes under scrutiny and review. Pharmacy benefit managers are taking center stage now. mark for My Articles similar articles
The Motley Fool
July 30, 2009
Brian Orelli
A Good Business Model for Bad Times Some businesses benefit when people are hurting. It's a beautiful time to be a pharmacy benefit manager, since that business model essentially results in them making more money when their customers save money. mark for My Articles similar articles
BusinessWeek
January 21, 2010
John Carey
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. mark for My Articles similar articles
The Motley Fool
June 30, 2011
David Williamson
Pharmacy Benefits Delivering Drama CVS claims another Medco client and one messy split. mark for My Articles similar articles
The Motley Fool
October 28, 2010
Our Top Stock Idea Our investing community's latest prime pick -- Medco Health Solutions. mark for My Articles similar articles
The Motley Fool
October 24, 2006
Brian Gorman
Medco's Fringe Benefits Recent developments will present some challenges, but Medco remains a solid long-term investment. mark for My Articles similar articles
Managed Care
October 2003
Medco Health Solutions tops consumer survey The 2003 WilsonRx Survey reports that patients have identified Medco Health Solutions as the top pharmacy benefit manager for the third year in a row. mark for My Articles similar articles
Managed Care
November 2005
John Carroll
FTC Report Arms PBMs In Battle With Drugstores Congress passed the Medicare Modernization Act allowing pharmacy benefits managers to participate in Medicare Part D. mark for My Articles similar articles
The Motley Fool
February 22, 2005
Brian Gorman
Novartis Embraces Generics The company is taking a different path from its branded pharmaceutical peers. The company's strategy may make its stock worth a closer look. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2008
Chris Biddle
Stop the Bleeding Pharmaceutical manufacturers overpay pharmacy benefit managers millions of dollars each year in rebate overpayments. Here's how to stop the leakage. mark for My Articles similar articles
Managed Care
October 2005
Health Plans Pay Less When PBM Owns Mail-Order Pharmacy The ongoing debate on whether health plans pay more for drugs when using a mail-order pharmacy owned by a pharmacy benefits manager (PBM) or when the mail-order pharmacy is not owned by a PBM may be closer to resolution. mark for My Articles similar articles
The Motley Fool
February 16, 2005
Brian Gorman
Medco's Double-Edged Sword The pharmacy benefit manager's latest financial report indicates that its business remains robust. But is it at the expense of retail pharmacies? mark for My Articles similar articles
The Motley Fool
August 16, 2010
Brian Orelli
The Fine Line Between Saving Money and Making It Medco's trying to walk it. mark for My Articles similar articles
The Motley Fool
April 27, 2005
Brian Gorman
Cautious on Medco Medco's earnings were respectable, but for now investors may want to step back. mark for My Articles similar articles
The Motley Fool
March 4, 2005
Tom Taulli
In the Express Scripts Lane Express Scripts' strong results bring a much-needed lift to health-care investors. mark for My Articles similar articles
BusinessWeek
March 7, 2005
Amy Barrett
A Drug Company On Growth Hormones By adding Accredo to its portfolio, Medco gains a strong presence in the area of specialty drugs. Investors sent Medco's stock down slightly on news of the deal. But they give company chief David B. Snow Jr. credit for putting Medco in a position to capitalize on new opportunities. mark for My Articles similar articles
The Motley Fool
November 19, 2010
Brian Orelli
How to Get Rich Buying This Trend As the baby boomers get older, the number of medical procedures and drugs that the average American takes will increase. mark for My Articles similar articles
The Motley Fool
October 6, 2011
Dan Caplinger
Has Medco Health Solutions Become the Perfect Stock? A lot has happened in the pharmacy benefits management space since we looked at Medco last year. mark for My Articles similar articles
The Motley Fool
March 26, 2010
Cathy Applefeld Olson
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup. mark for My Articles similar articles
The Motley Fool
November 8, 2006
Michael P. Cecil
CVS/Caremark: A Brobdingnagian Drug Seller The merger of CVS and Caremark says a lot about pharmaceutical retailers and pharmacy benefit mangers trying to deal with a rapidly changing paradigm. mark for My Articles similar articles
The Motley Fool
February 25, 2009
Brian Orelli
The Best Kind of Generic Growth Pharmacy benefit managers profit from penny-pinchers. mark for My Articles similar articles
The Motley Fool
October 30, 2006
Brian Lawler
Celgene: Drug Kingpin Trading at 129 times trailing-12-month adjusted earnings, the biopharmaceutical looks ridiculously expensive, until one considers its awesome sales and earnings growth in that time period. Investors, take note. mark for My Articles similar articles
The Motley Fool
November 4, 2009
Brian Orelli
This One Is Thriving in a Recession Saving customers money makes it easy for Medco. mark for My Articles similar articles
The Motley Fool
July 25, 2011
Brian Orelli
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. mark for My Articles similar articles
Managed Care
December 2003
Tony Berberabe
Why Do FEHBP and Big Unions Excel at Managing Drug Costs? Pharmacy benefit managers can do only so much to keep drug price increases in the single digits. Initiatives instituted by health plans can help in this effort. mark for My Articles similar articles
The Motley Fool
April 30, 2008
Brian Orelli
Medco's Far-From-Generic Quarter Pharmacy benefit manager Medco Health Solutions benefits from new generic drugs. mark for My Articles similar articles